Source: International Congress 2018 – Airway disease: recent discoveries
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Scarlata (Rome, Italy), S. Santangelo (Rome, Italy), P. Finamore (Rome, Italy), G. Giannunzio (Rome, Italy), D. Fontana (Rome, Italy), R. Antonelli Incalzi (Rome, Italy). Alpha 1-globulin fraction of serum protein electrophoresis for screening and early detection of alpha 1 antitrypsin deficiency. 4424

Member's Comments

No comment yet.

Related content which might interest you: Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Alpha 1 - antitrypsin deficiency: diagnosis and treatment Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment Year: 2021 Alpha-1 antitrypsin phenotype determination using sebia isoelectrofocusing on dried blood spot samples Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 A high purity alpha-1 antitrypsin (AAT) from human plasma, TAL6004 Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Alpha 1-antitrypsin deficiency Source: Breathe 2008; 4: 377-380 Year: 2008 Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Routine serum protein electrophoresis and detection of alpha1-antitrypsin deficiency Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Epithelial cell biology Year: 2010 Initial values of alpha 1 antitrypsin and transferrin in patients with pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 660s Year: 2007 Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 Alpha-1 antitrypsin (AAT) and alpha-2 macroglobulin (AMG) levels according to the stages and histological types in lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm Source: Eur Respir Rev 2015; 24: 52-57 Year: 2015 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Rapid DNA extraction from dried blood spots for the alpha-1 antitrypsin deficiency detection by real-time PCR Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 Effects of double dose alpha 1 antitrypsin (AAT) therapy on cytokine pathways in AAT Deficiency (AATD) Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021